March 3, 2007
Pharmacosmos participates in the 8th Annual NATA Symposium (Network for Advancement of Transfusion Alternatives). The symposium will take place on April 20-21, 2007, at the Budapest Congress & World Trade Center, Jagelló út 1-3, 1123 Budapest, Hungary.
For additional information about the 8th Annual NATA Symposium, please visit the NATA Website.
About Pharmacosmos A/S
Pharmacosmos develops and markets
medicines for the treatment of iron deficiency. A research-based
company, its ongoing R&D programme focuses on improving the
treatment options for healthcare professionals, patients suffering
from iron deficiency and veterinary treatments. .
Pharmacosmos is a family-owned
Danish company and operates in more than 50 countries across
Europe, the Americas and Asia. Its facilities are approved by both
the Danish Medicines Agency and the US Food & Drug
Administration.